首页> Frontiers in immunology> Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons.

Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons.

导出 LinkOut

翻译打印收藏纠错

第一作者： Katalin A,Wilkinson

第一单位： Tuberculosis Laboratory, The Francis Crick Institute, London, United Kingdom.;Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

作者： Katalin A,Wilkinson ^[1] ; Deborah,Schneider-Luftman ^[2] ; Rachel,Lai ^[3] ; Christopher,Barrington ^[2] ; Nishtha,Jhilmeet ^[4] ; David M,Lowe ^[5] ; Gavin,Kelly ^[2] ; Robert J,Wilkinson ^[6]

作者单位： Tuberculosis Laboratory, The Francis Crick Institute, London, United Kingdom.;Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. ^[1] Bioinformatics and Biostatistics, The Francis Crick Institute, London, United Kingdom. ^[2] Department of Infectious Disease, Imperial College London, London, United Kingdom. ^[3] Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. ^[4] Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.;Institute of Immunity and Transplantation, University College London, London, United Kingdom. ^[5] Tuberculosis Laboratory, The Francis Crick Institute, London, United Kingdom.;Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.;Department of Infectious Disease, Imperial College London, London, United Kingdom. ^[6]

关键词 QuantiFERON RNAseq antiretroviral treatment plasma biomarker tuberculosis